Sunshine Biopharma (SBFM) Exchange Rate Effect (2015 - 2026)
Sunshine Biopharma's (SBFM) quarterly Exchange Rate Effect came in at -$33677.0 in Q1 2026, down 230.26% YoY from $25852.9 in Q1 2025, and down 104.44% on a QoQ basis from $758585.0 in Q4 2025.
Sunshine Biopharma (SBFM) Exchange Rate Effect (2015 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 12 years of Exchange Rate Effect data on file, last reported at -$33677.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 230.26% year-over-year to -$33677.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $832270.0 (up 169.66% YoY) and the FY2025 annual result came in at $855750.0, up 182.02% from the prior year.
- Exchange Rate Effect eased to -$33677.0 in Q1 2026, from $758585.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $772282.0 in Q3 2024 to a low of -$1.3 million in Q2 2024.
- A 5-year average of $18350.5 and a median of -$1007.0 in 2022 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 5577.46% in 2024, down 418.6% in 2024.
- Tracing SBFM's Exchange Rate Effect over 5 years: stood at $104542.0 in 2022, then surged by 376.66% to $498306.0 in 2023, then sank by 227.49% to -$635298.0 in 2024, then jumped by 219.41% to $758585.0 in 2025, then tumbled by 104.44% to -$33677.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$33677.0 (Q1 2026), $758585.0 (Q4 2025), and -$228322.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Sunshine Biopharma | 1.58 Mn | -12.17 Mn | 2.43 Mn | -45,800.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -45,800.00 |
| Jun 30, 2026 | -45,800.00 |
| Mar 31, 2026 | -33,677.00 |
| Mar 31, 2026 | -33,677.00 |
| Dec 31, 2025 | 758,585.00 |
| Dec 31, 2025 | 758,585.00 |
| Sep 30, 2025 | -228,322.00 |
| Sep 30, 2025 | -228,322.00 |
| Jun 30, 2025 | 335,684.00 |
| Jun 30, 2025 | 335,684.00 |
| Mar 31, 2025 | -10,197.00 |
| Mar 31, 2025 | -10,197.00 |
| Dec 31, 2024 | -635,298.00 |
| Dec 31, 2024 | -635,298.00 |
| Sep 30, 2024 | 772,282.00 |
| Sep 30, 2024 | 772,282.00 |
| Jun 30, 2024 | -1.32 Mn |
| Jun 30, 2024 | -1.32 Mn |
| Mar 31, 2024 | 141,312.00 |
| Mar 31, 2024 | 141,312.00 |